Skip to content
TheChatArchiveThe Chat Archive
gpt-4-0125-preview· OpenAIAi2 WildChat-4.8M (AI2)

Make practice questions from these notes: Recall principles of ABO matching for blood…

  1. User

    Make practice questions from these notes: Recall principles of ABO matching for blood transfusion and events that can occur due to Rh incompatibility Review HDN and MOA of RhoGam HDN hemolytic disease of newborn- RhoGam- prevents mother’s immune system attacks Rh+ newborn lysing the RBCs Define crossmatch: Know when and why it is used Mix recipient’s serum with donors RBCs to look for agglutination List three main types of transplant SOT (Solid organ transplant)-
    BMT (Bone marrow transplant) HSCT (Hematopoeitic stem cell transplant) Define autologous, allogeneic, xenographic Discriminate between and describe hyperacute, acute, and chronic rejection with regards to solid organ transplant (SOT) Know timing of reactions (is it hours, days, months?) Know effectors of immune response which leads to rejection Contrast immune mechanisms of rejection types Identify hypersensitivity reaction type Know that there are ways to acquire anti-HLA antibodies Diagram mixed lymphocyte reaction (MLR) Diagram direct and indirect allorecognition Direct allorecognition- Receipt T cell recognizes antigen on donor’s DC (acute rejection- 1-3 months) Indirect allorecognition- Receipt T cell recognizes antigen on receipt’s DC (chronic rejection- within 10 years) Remember that there is a small population of allogeneic T cells that will recognize nonself MHC: peptide (these same T cells can still recognize self MHC:peptide) Know treatment and/or prevention methods of SOT as appropriate Minimize allogenic differences Immunosuppression Understand the principle of using immunosuppressive drugs for treatment of/ during transplantation List 4 categories of immunosuppressive drugs and in general why they would be used with respect to outcome Anti-lymphocyte antibodies OKT3- mouse monoclonal antibody for CD3 Anti-thymocyte globulin (ATG)- horse or rabbit antibody for all T cells Anti-IL2Ralpha receptor antibody- humanized antibody for IL-2Ralpha. Decreases activated T cells Costimulatory blockade CTLA4-Ig → acts like CTLA4 T-cell signaling inhibitors NFAT → calcineurin inhibitors to prevent dephosphorylation preventing NFAT from going into the nucleus. Cyclosporin A binds cyclophilins and Tacrolimus binds FKBP Antimetabolites- metabolic toxins that inhibit the proliferation of lymphocyte precursors Azathioprine- inhibits the synthesis of adenine and guanine Anti-inflammatory drugs Corticosteroids Specifically know category, basic mechanism of action and when the following treatments may be used with respect to transplantation Prednisone Azathioprine Cyclosporin Tacrolimus Daclizumab Know that immunosuppressive treatments puts patient at risk for infections Appreciate why liver and corneas have different requirements for matching Describe mechanism of Graft vs Host Disease (GVHD) that occurs as a result of a bone marrow transplant (BMT) Know how to prevent GVHD Know how to identify best HLA match based on haplotype and donor/recipient relationship Appreciate how GVHD can be beneficial in a BMT

    For BMT and HSCT (hemapoietic stem cell transplant) understand the immunological concepts but don’t worry about any of the clinical details

  2. Assistant
    1. ABO Matching Principles:

      • Regarding blood transfusions, explain why it's crucial to match the ABO blood group of the donor and recipient.
    2. Rh Incompatibility:

      • What are potential complications of Rh incompatibility during blood transfusion?
    3. Hemolytic Disease of the Newborn (HDN):

      • Describe how RhoGam works to prevent HDN.
    4. Crossmatch Procedure:

      • Why is a crossmatch test performed before a blood transfusion?
    5. Types of Transplants:

      • List the three main types of transplants and give a brief description of each.
    6. Transplant Terminology:

      • Define autologous, allogeneic, and xenogeneic transplants.
    7. Rejection Types in SOT:

      • Differentiate between hyperacute, acute, and chronic rejection in solid organ transplants regarding timing and immune effectors involved.
    8. Hypersensitivity Reactions in Transplants:

      • Identify which types of hypersensitivity reactions can be linked to organ transplant rejections.
    9. Mixed Lymphocyte Reaction (MLR):

      • What is the purpose of conducting a mixed lymphocyte reaction (MLR) in the context of transplantation?
    10. Allorecognition Pathways:

      • Describe the differences between direct and indirect allorecognition in transplant rejection.
    11. Treatment and Prevention of SOT Rejection:

      • What are the primary methods used to treat or prevent rejection in solid organ transplantation?
    12. Immunosuppressive Drugs:

      • List the four categories of immunosuppressive drugs used in transplantation and describe the general mechanism of action for each category.
    13. Treatment Specifics:

      • Explain when and why Prednisone, Azathioprine, Cyclosporin, Tacrolimus, and Daclizumab are used in the context of transplantation.
    14. Immunosuppression Side Effects:

      • Discuss how immunosuppressive treatments can increase a patient's risk for infections.
    15. Matching Requirements for Transplants:

      • Explain why liver and cornea transplants have different requirements for HLA matching compared to other organ transplants.
    16. Graft versus Host Disease (GVHD):

      • Describe the mechanism of GVHD that occurs as a result of a bone marrow transplant (BMT) and discuss strategies to prevent it.
    17. HLA Matching and GVHD:

      • How can GVHD be beneficial in the context of bone marrow transplantation, and what is the best approach to identify the ideal HLA match for BMT?

    Remember, these questions are designed to test your understanding of the key concepts related to blood transfusion, Rh incompatibility, transplant types, immune response in transplantation, and treatment/prevention of transplant rejection.

  3. User

    Make multiple choice questions using these notes and also list the answers to them at the end: Recall principles of ABO matching for blood transfusion and events that can occur due to Rh incompatibility Review HDN and MOA of RhoGam HDN hemolytic disease of newborn- RhoGam- prevents mother’s immune system attacks Rh+ newborn lysing the RBCs Define crossmatch: Know when and why it is used Mix recipient’s serum with donors RBCs to look for agglutination List three main types of transplant SOT (Solid organ transplant)-
    BMT (Bone marrow transplant) HSCT (Hematopoeitic stem cell transplant) Define autologous, allogeneic, xenographic Discriminate between and describe hyperacute, acute, and chronic rejection with regards to solid organ transplant (SOT) Know timing of reactions (is it hours, days, months?) Know effectors of immune response which leads to rejection Contrast immune mechanisms of rejection types Identify hypersensitivity reaction type Know that there are ways to acquire anti-HLA antibodies Diagram mixed lymphocyte reaction (MLR) Diagram direct and indirect allorecognition Direct allorecognition- Receipt T cell recognizes antigen on donor’s DC (acute rejection- 1-3 months) Indirect allorecognition- Receipt T cell recognizes antigen on receipt’s DC (chronic rejection- within 10 years) Remember that there is a small population of allogeneic T cells that will recognize nonself MHC: peptide (these same T cells can still recognize self MHC:peptide) Know treatment and/or prevention methods of SOT as appropriate Minimize allogenic differences Immunosuppression Understand the principle of using immunosuppressive drugs for treatment of/ during transplantation List 4 categories of immunosuppressive drugs and in general why they would be used with respect to outcome Anti-lymphocyte antibodies OKT3- mouse monoclonal antibody for CD3 Anti-thymocyte globulin (ATG)- horse or rabbit antibody for all T cells Anti-IL2Ralpha receptor antibody- humanized antibody for IL-2Ralpha. Decreases activated T cells Costimulatory blockade CTLA4-Ig → acts like CTLA4 T-cell signaling inhibitors NFAT → calcineurin inhibitors to prevent dephosphorylation preventing NFAT from going into the nucleus. Cyclosporin A binds cyclophilins and Tacrolimus binds FKBP Antimetabolites- metabolic toxins that inhibit the proliferation of lymphocyte precursors Azathioprine- inhibits the synthesis of adenine and guanine Anti-inflammatory drugs Corticosteroids Specifically know category, basic mechanism of action and when the following treatments may be used with respect to transplantation Prednisone Azathioprine Cyclosporin Tacrolimus Daclizumab Know that immunosuppressive treatments puts patient at risk for infections Appreciate why liver and corneas have different requirements for matching Describe mechanism of Graft vs Host Disease (GVHD) that occurs as a result of a bone marrow transplant (BMT) Know how to prevent GVHD Know how to identify best HLA match based on haplotype and donor/recipient relationship Appreciate how GVHD can be beneficial in a BMT

    For BMT and HSCT (hemapoietic stem cell transplant) understand the immunological concepts but don’t worry about any of the clinical details

  4. Assistant

    Multiple Choice Questions:

    1. What is the main purpose of RhoGam in pregnancy? A. Increase Rh+ antibodies in the mother B. Prevent the mother's immune system from attacking Rh+ newborn RBCs C. Enhance Rh incompatibility between mother and fetus D. Prevent HDN in Rh- newborns

    2. A crossmatch test before a blood transfusion is primarily used to: A. Determine the blood type of the donor B. Look for agglutination between recipient’s serum and donor's RBCs C. Identify the Rh factor of the donor D. Select the best type of immunosuppressive drug

    3. Which of the following is NOT a type of organ transplant? A. Solid organ transplant (SOT) B. Blood marrow transplant (BMT) C. Hematopoietic stem cell transplant (HSCT) D. Epithelial cell transplant (ECT)

    4. Hyperacute rejection of a solid organ transplant occurs: A. Within minutes to hours after transplant B. 1-3 months post-transplant C. Within 10 years post-transplant D. After 10 years post-transplant

    5. The mechanism of direct allorecognition in transplant rejection involves: A. Recipient T cells recognizing donor antigens on recipient's dendritic cells B. Recipient T cells recognizing donor antigens on donor's dendritic cells C. Donor T cells recognizing recipient antigens on recipient's dendritic cells D. Donor T cells recognizing recipient antigens on donor's dendritic cells

    6. Which immunosuppressive drug category includes agents that act by blocking costimulatory signals? A. Anti-lymphocyte antibodies B. Costimulatory blockade C. T-cell signaling inhibitors D. Antimetabolites

    7. Which method is NOT a treatment or prevention strategy for solid organ transplant rejection? A. Minimizing allogenic differences B. Enhancing immune response towards the transplanted organ C. Using immunosuppressive drugs D. Performing mixed lymphocyte reactions (MLR) before transplantation

    8. What is the primary risk associated with immunosuppressive treatments in transplanted patients? A. Hyperacute rejection B. Chronic rejection C. Increased risk for infections D. Graft versus Host Disease (GVHD)

    9. Graft versus Host Disease (GVHD) is a major complication of: A. Solid organ transplant (SOT) B. Bone marrow transplant (BMT) C. Hematopoietic stem cell transplant (HSCT) D. Autologous transplant

    10. What is the mechanism of action for Calcineurin inhibitors such as Cyclosporin? A. Binds to cyclophilins and inhibits NFAT dephosphorylation B. Acts as a metabolic toxin to inhibit lymphocyte proliferation C. Blocks the IL-2 receptor alpha D. Mimics the action of CTLA4

    Answers:

    1. B. Prevent the mother's immune system from attacking Rh+ newborn RBCs
    2. B. Look for agglutination between recipient’s serum and donor's RBCs
    3. D. Epithelial cell transplant (ECT)
    4. A. Within minutes to hours after transplant
    5. B. Recipient T cells recognizing donor antigens on donor's dendritic cells
    6. B. Costimulatory blockade
    7. B. Enhancing immune response towards the transplanted organ
    8. C. Increased risk for infections
    9. B. Bone marrow transplant (BMT)
    10. A. Binds to cyclophilins and inhibits NFAT dephosphorylation
  5. User

    Make multiple choice questions using these notes and also list the answers to them at the end: Primary immunodeficiencies- inherited defect leading to a block in maturation or function of different components of the immune system

    Secondary immunodeficiencies- acquired immunodeficiency secondary to an extrinsic cause

    All immunodeficiencies share a common feature of recurrent infections

    B cell IDs have pyogenic/encapsulated bacterial infections T cell IDs have recurrent viral or fungal infection and Virus associated malignancies Innate IDs have variable; pyogenic/ encapsulated bacterial infections

    Defects in molecules involved in tolerance can lead to autoimmunity and/or cancer Defects in molecular regulators of inflammation result in autoinflammatory diseases

    Most common → Least common IDs Antibody disorders T cell Phagocytic Complement Others

    Antibody disorders Manifest around 5-6 months after maternal antibodies are depleted except CVID which shows up in later childhood and adulthood Recurrent sinopulmonary infections with encapsulated bacteria such as S. pneumoniae and H. influenzae Due to lack of antibodies needed to opsonize and phagocytize encapsulated bacteria Treatment- IVIG and prophylactic antimicrobials Examples: XLA- BTK defect Stops pro-B → pre-B leading to low B cell(CD19+) and low # of all Igs Treatment- IVIG and antimicrobials Hyper IgM- high levels of IgM 2 causes: CD40L deficiency and AID deficiency CD40L- X-linked Impaired B and T cell functions AID- AR Impaired B cells but T cells are normal. B cell cannot isotype switch CVID- Caused by defects in BAFF R (B cell development and survival) and TACI (isotype switching) Commonly diagnosed in 20-30s. Hypogammaglobulinemia with low serum IgG and low IgA or IgM or both. Labs- Impaired response to antigens Normal B cell numbers but low memory B cell Memory B cells cannot undergo class-switching Severe deficiency of plasma cells and impaired somatic hypermutation Some T cell dysfunction in some patients Presentation- Recurrent sinopulmonary infections Giardia and Mycoplasma infections Enteropathy, 20% develop an autoimmunity Treatment- IVIG Selective Ig deficiencies (commonly IgA)- Low IgA only. Increased sinopulmonary and GI infections. Increased atopy and autoimmune diseases. Treatment- antimicrobials

    T cell

    Early infancy to early childhood onset. Susceptible to intracellular pathogens such as Mycobacteria, Toxoplasma gondii, Leishmania, Pneumocystis jirovecci, and viruses Severe T cell deficiencies can affect B cell function leading to SCID Labs- Lymphopenia Absent DTH (Delayed type hypersensitivity) response Treatment- HSCT

    Mitogens- polyclonal activators of T and B cells. Used to assess ability of lymphocytes to proliferate MHC class I (Bare Lymphocyte Syndrome I)- Lack of MHC I Hyper IgE syndrome (HIES, Job’s Syndrome)- AD STAT3 defect leading to defective TH17 lineage differentiation (neutrophils). Inability to respond to skin and mucosal infections due to poor neutrophil recruitment and lack of antimicrobial peptides Triad of clinical symptoms- recurrent S. aureus cold abscesses, pneumonia, and high serum IgE Severe eczema, non-red and non-tender pustules, asymmetrical face, broad nose, deep-set eyes, big forehead, delayed shedding of primary teeth. “FATED” Coarse Fascial features Cold Staph Abscess Retained 1° Teeth Increased IgE Eczema: Dermatologic problems Hyper IgM (CD40L deficiency)- X-linked Impaired B and T cell functions Wiskott-Aldrich Syndrome (WAS)- X-linked. WAS gene mutation for WAS protein (WASp) only in leukocytes and megakaryocytes. WASp is a regulator of B and T cell and platelet development and function through its receptor-mediated signals involved in actin cytoskeleton reorganization. Thrombocytopenia, Eczema, and severe recurrent infections of pyogenic and opportunistic Platelets reduced in size and number Abnormal bleeding (Petechiae and easy bruising) and bloody diarrhea secondary to thrombocytopenia Susceptible to autoimmunity such as hemolytic anemia and vasculitis T cells abnormal numbers and function due to loss of movement, microvilli, immune synapse formation, cytotoxic function Low IgM, no isohemagglutinin and low response to polysaccharides. Normal IgG and increased IgE and IgA Motility and phagocytosis defects in monocytes, macrophages, and dendritic cells Treatment- IVIG, prophylactic antimicrobials, avoid trauma-related bleeding, HSCT, and Gene therapy

    SCID= Both T and B cell are lacking or compromised Mutation in both T and B cells Severe T cell deficiency that can affect the function of B cells Prone to opportunistic infections such as Adenoviruses, Epstein Bar virus, Candida albicans, and P. jirovecii TRECS and HSCT or Thymus replacement for Complete DiGeorge 3 major defects lead to SCID Defects in T cell differentiation- X-linked SCID most common Defects in TCR rearrangement- Omenn syndrome Defects in purine salvage pathway- Adenosine deaminase (ADA) or purine nucleotide (PNP) deficiencies Complete DiGeorge syndrome- 22q11 chromosome defect → no thymus Omenn syndrome- leaky Missense mutation in RAG genes T-B-NK+ X-linked SCID- Mutated IL-2R gene gamma chain. T-B+NK- Adenosine Deaminase Deficiency (ADA)- T-B-NK- Purine Nucleoside Phosphorylase Deficiency (PNP)- T-B-NK-

    Diseases that lead to autoimmunity ALPS- AD Fas defect → uncontrolled T cell proliferation without infection or cancer Splenomegaly and lymphadenopathy Test- large number of CD3+ CD4- CD8- T cells (DN) Autoimmune polyendocrinopathy candidiasis (APECED)- No AIRE → self reactive T cells Immune dysregulation, polyendocrinopathy, enteropathy X-linked disease (IPEX)- X-linked Mutated FOXP3 → lack of Treg tolerance Dermatitis, diarrhea, failure to thrive Systemic autoimmunity triad: Autoimmune enteropathy Autoimmune endocrinopathies Eczematous dermatitis Treatment- HSC

    Complement deficiencies - NOT ON EXAM 3 C3 deficiency- recurrent bacterial infections Properdin or terminal component deficiencies- Neisseria meningitides MBL deficiency- recurrent pneumonia infections in infants Paroxysmal nocturnal hemaglobulinuria (PNH) Hereditary angioedema (HAE) Factor I deficiency

    Phagocytic deficiencies Compromised ability to clear infections due to phagocytosis problems Prone to S. Aureus, fungi and gram-negative bacteria LAD- 2 types I and II I is AR defect in Beta 2 integrin chain of LFA-1 → defect in migration of phagocytes to site of infection II is impaired fucosylation of Leukocyte adhesion molecule sialyl-Lewis-X (CD15) Poor wound healing CGD- Mutated NADPH Oxidase → Impaired killing of phagocytosed bacteria Two testing methods Neutrophils mixed with Phorbol myristate acetate (PMA) and Nitroblue tetrazolium (NBT) which is reduced to dark purple formazan in normal phagocytes Neutrophils mixed with dihydrorhodamine (DHR) with PMA. DHR is oxidized to rhodamine in normal phagocytes CHS- Mutated Lyst (CHS1) gene → Impaired ability to form and traffic vesicles. Azurophilic granules in phagocytic cells. Decrease in neutrophils, intracellular microbial activity Impaired in CD8+ T cell and NK cell cytotoxicity Frequent S aureus, S pyogenes, and S pneumonia infections Lack of pigmentation- albinism Adolescence develop progressive neurological problems Treatment- HSCT

    Defects in innate immunity

    X-linked Hypohidrotic Ectodermal Dysplasia (NEMO deficiency)- IKK-gamma, Recurrent pyogenic infections, abnormal hair, teeth (cone shaped), skin

    Autoinflammatory syndrome- primary immunodeficiency in intracellular receptors in innate immunity leading to uncontrolled inflammation.

    Secondary immunodeficiencies Causes: Irradiation and chemotherapy (immunosuppression) Bone marrow cancers Protein-calorie malnutrition Premature aging Infections

    Immunosenescence- aging of immune system. More prone to infections Less protected by vaccines Longer more severe poorer prognosis of diseases Reactivation of Varicella-zoster and M. tuberculosis Risks forPpneumonia, UTIs, Meningitis, and Gastroenteritis Infections- HIV gp41 — CD4 gp120 — CCR5 or CXCR4 (chemokine receptors)

    Leads to Acquired immunodeficiencies (AIDs) Drugs inhibit - reverse transcriptase, intergrase, and protease activity

  6. Assistant
    1. Primary immunodeficiencies are mainly characterized by: A. Inheritance of specific traits. B. Acquired defects due to lifestyle choices. C. Inherited defects leading to a block in the maturation or function of different components of the immune system. D. Always being present at birth.

    2. Which of the following infections are individuals with B cell immunodeficiencies MOST susceptible to? A. Intracellular pathogens like Mycobacteria. B. Pyogenic or encapsulated bacterial infections. C. Opportunistic fungal infections. D. Viral-associated malignancies.

    3. The common treatment for antibody disorders such as XLA includes: A. High doses of oral antibiotics only. B. IVIG and prophylactic antimicrobials. C. Hematopoietic stem cell transplantation (HSCT). D. Gene therapy.

    4. Which of the following is a characteristic symptom of Hyper IgM syndrome? A. Low levels of IgG and IgA, with normal IgM. B. High levels of IgM with defects in isotype switching. C. Increased IgE leading to severe allergic reactions. D. Deficiency in all immunoglobulin classes.

    5. T cell deficiencies make individuals more susceptible to: A. Encapsulated bacterial infections only. B. Recurrent viral or fungal infections and virus-associated malignancies. C. Sinopulmonary infections. D. Autoimmune diseases.

    6. Severe Combined Immunodeficiency (SCID) is characterized by: A. Only B cell deficiency. B. Only T cell deficiency. C. Both T and B cell being lacking or compromised. D. Deficiency in innate immune components.

    7. Wiskott-Aldrich Syndrome (WAS) is marked by all EXCEPT: A. Thrombocytopenia and eczema. B. High IgM levels. C. Recurrent infections of pyogenic and opportunistic nature. D. Abnormal bleeding due to thrombocytopenia.

    8. Which of the following leads to a T-B+NK- phenotype in SCID? A. Adenosine Deaminase Deficiency (ADA). B. X-linked SCID due to mutated IL-2R gamma chain. C. Omenn syndrome. D. Complete DiGeorge syndrome.

    9. In the context of secondary immunodeficiencies, which of the following can cause acquired immunodeficiency? A. Genetic inheritance. B. Irradiation and chemotherapy. C. Overactive immune response. D. High levels of physical activity.

    10. Autoimmune polyendocrinopathy candidiasis-ectodermal dystrophy (APECED) is the result of: A. A deficiency in BAFF R. B. An X-linked mutation in FOXP3. C. A deficiency in AIRE, leading to self-reactive T cells. D. A defect in BTK, leading to low B cell numbers.

    Answers:

    1. C. Inherited defects leading to a block in the maturation or function of different components of the immune system.
    2. B. Pyogenic or encapsulated bacterial infections.
    3. B. IVIG and prophylactic antimicrobials.
    4. B. High levels of IgM with defects in isotype switching.
    5. B. Recurrent viral or fungal infections and virus-associated malignancies.
    6. C. Both T and B cell being lacking or compromised.
    7. B. High IgM levels.
    8. B. X-linked SCID due to mutated IL-2R gamma chain.
    9. B. Irradiation and chemotherapy.
    10. C. A deficiency in AIRE, leading to self-reactive T cells.
  7. User

    Make multiple choice questions testing all of these concepts and also list the answers to them at the end: Primary immunodeficiencies- inherited defect leading to a block in maturation or function of different components of the immune system

    Secondary immunodeficiencies- acquired immunodeficiency secondary to an extrinsic cause

    All immunodeficiencies share a common feature of recurrent infections

    B cell IDs have pyogenic/encapsulated bacterial infections T cell IDs have recurrent viral or fungal infection and Virus associated malignancies Innate IDs have variable; pyogenic/ encapsulated bacterial infections

    Defects in molecules involved in tolerance can lead to autoimmunity and/or cancer Defects in molecular regulators of inflammation result in autoinflammatory diseases

    Most common → Least common IDs Antibody disorders T cell Phagocytic Complement Others

    Antibody disorders Manifest around 5-6 months after maternal antibodies are depleted except CVID which shows up in later childhood and adulthood Recurrent sinopulmonary infections with encapsulated bacteria such as S. pneumoniae and H. influenzae Due to lack of antibodies needed to opsonize and phagocytize encapsulated bacteria Treatment- IVIG and prophylactic antimicrobials Examples: XLA- BTK defect Stops pro-B → pre-B leading to low B cell(CD19+) and low # of all Igs Treatment- IVIG and antimicrobials Hyper IgM- high levels of IgM 2 causes: CD40L deficiency and AID deficiency CD40L- X-linked Impaired B and T cell functions AID- AR Impaired B cells but T cells are normal. B cell cannot isotype switch CVID- Caused by defects in BAFF R (B cell development and survival) and TACI (isotype switching) Commonly diagnosed in 20-30s. Hypogammaglobulinemia with low serum IgG and low IgA or IgM or both. Labs- Impaired response to antigens Normal B cell numbers but low memory B cell Memory B cells cannot undergo class-switching Severe deficiency of plasma cells and impaired somatic hypermutation Some T cell dysfunction in some patients Presentation- Recurrent sinopulmonary infections Giardia and Mycoplasma infections Enteropathy, 20% develop an autoimmunity Treatment- IVIG Selective Ig deficiencies (commonly IgA)- Low IgA only. Increased sinopulmonary and GI infections. Increased atopy and autoimmune diseases. Treatment- antimicrobials

    T cell

    Early infancy to early childhood onset. Susceptible to intracellular pathogens such as Mycobacteria, Toxoplasma gondii, Leishmania, Pneumocystis jirovecci, and viruses Severe T cell deficiencies can affect B cell function leading to SCID Labs- Lymphopenia Absent DTH (Delayed type hypersensitivity) response Treatment- HSCT

    Mitogens- polyclonal activators of T and B cells. Used to assess ability of lymphocytes to proliferate MHC class I (Bare Lymphocyte Syndrome I)- Lack of MHC I Hyper IgE syndrome (HIES, Job’s Syndrome)- AD STAT3 defect leading to defective TH17 lineage differentiation (neutrophils). Inability to respond to skin and mucosal infections due to poor neutrophil recruitment and lack of antimicrobial peptides Triad of clinical symptoms- recurrent S. aureus cold abscesses, pneumonia, and high serum IgE Severe eczema, non-red and non-tender pustules, asymmetrical face, broad nose, deep-set eyes, big forehead, delayed shedding of primary teeth. “FATED” Coarse Fascial features Cold Staph Abscess Retained 1° Teeth Increased IgE Eczema: Dermatologic problems Hyper IgM (CD40L deficiency)- X-linked Impaired B and T cell functions Wiskott-Aldrich Syndrome (WAS)- X-linked. WAS gene mutation for WAS protein (WASp) only in leukocytes and megakaryocytes. WASp is a regulator of B and T cell and platelet development and function through its receptor-mediated signals involved in actin cytoskeleton reorganization. Thrombocytopenia, Eczema, and severe recurrent infections of pyogenic and opportunistic Platelets reduced in size and number Abnormal bleeding (Petechiae and easy bruising) and bloody diarrhea secondary to thrombocytopenia Susceptible to autoimmunity such as hemolytic anemia and vasculitis T cells abnormal numbers and function due to loss of movement, microvilli, immune synapse formation, cytotoxic function Low IgM, no isohemagglutinin and low response to polysaccharides. Normal IgG and increased IgE and IgA Motility and phagocytosis defects in monocytes, macrophages, and dendritic cells Treatment- IVIG, prophylactic antimicrobials, avoid trauma-related bleeding, HSCT, and Gene therapy

    SCID= Both T and B cell are lacking or compromised Mutation in both T and B cells Severe T cell deficiency that can affect the function of B cells Prone to opportunistic infections such as Adenoviruses, Epstein Bar virus, Candida albicans, and P. jirovecii TRECS and HSCT or Thymus replacement for Complete DiGeorge 3 major defects lead to SCID Defects in T cell differentiation- X-linked SCID most common Defects in TCR rearrangement- Omenn syndrome Defects in purine salvage pathway- Adenosine deaminase (ADA) or purine nucleotide (PNP) deficiencies Complete DiGeorge syndrome- 22q11 chromosome defect → no thymus Omenn syndrome- leaky Missense mutation in RAG genes T-B-NK+ X-linked SCID- Mutated IL-2R gene gamma chain. T-B+NK- Adenosine Deaminase Deficiency (ADA)- T-B-NK- Purine Nucleoside Phosphorylase Deficiency (PNP)- T-B-NK-

    Diseases that lead to autoimmunity ALPS- AD Fas defect → uncontrolled T cell proliferation without infection or cancer Splenomegaly and lymphadenopathy Test- large number of CD3+ CD4- CD8- T cells (DN) Autoimmune polyendocrinopathy candidiasis (APECED)- No AIRE → self reactive T cells Immune dysregulation, polyendocrinopathy, enteropathy X-linked disease (IPEX)- X-linked Mutated FOXP3 → lack of Treg tolerance Dermatitis, diarrhea, failure to thrive Systemic autoimmunity triad: Autoimmune enteropathy Autoimmune endocrinopathies Eczematous dermatitis Treatment- HSC

    Complement deficiencies - NOT ON EXAM 3 C3 deficiency- recurrent bacterial infections Properdin or terminal component deficiencies- Neisseria meningitides MBL deficiency- recurrent pneumonia infections in infants Paroxysmal nocturnal hemaglobulinuria (PNH) Hereditary angioedema (HAE) Factor I deficiency

    Phagocytic deficiencies Compromised ability to clear infections due to phagocytosis problems Prone to S. Aureus, fungi and gram-negative bacteria LAD- 2 types I and II I is AR defect in Beta 2 integrin chain of LFA-1 → defect in migration of phagocytes to site of infection II is impaired fucosylation of Leukocyte adhesion molecule sialyl-Lewis-X (CD15) Poor wound healing CGD- Mutated NADPH Oxidase → Impaired killing of phagocytosed bacteria Two testing methods Neutrophils mixed with Phorbol myristate acetate (PMA) and Nitroblue tetrazolium (NBT) which is reduced to dark purple formazan in normal phagocytes Neutrophils mixed with dihydrorhodamine (DHR) with PMA. DHR is oxidized to rhodamine in normal phagocytes CHS- Mutated Lyst (CHS1) gene → Impaired ability to form and traffic vesicles. Azurophilic granules in phagocytic cells. Decrease in neutrophils, intracellular microbial activity Impaired in CD8+ T cell and NK cell cytotoxicity Frequent S aureus, S pyogenes, and S pneumonia infections Lack of pigmentation- albinism Adolescence develop progressive neurological problems Treatment- HSCT

    Defects in innate immunity

    X-linked Hypohidrotic Ectodermal Dysplasia (NEMO deficiency)- IKK-gamma, Recurrent pyogenic infections, abnormal hair, teeth (cone shaped), skin

    Autoinflammatory syndrome- primary immunodeficiency in intracellular receptors in innate immunity leading to uncontrolled inflammation.

    Secondary immunodeficiencies Causes: Irradiation and chemotherapy (immunosuppression) Bone marrow cancers Protein-calorie malnutrition Premature aging Infections

    Immunosenescence- aging of immune system. More prone to infections Less protected by vaccines Longer more severe poorer prognosis of diseases Reactivation of Varicella-zoster and M. tuberculosis Risks forPpneumonia, UTIs, Meningitis, and Gastroenteritis Infections- HIV gp41 — CD4 gp120 — CCR5 or CXCR4 (chemokine receptors)

    Leads to Acquired immunodeficiencies (AIDs) Drugs inhibit - reverse transcriptase, intergrase, and protease activity

  8. Assistant

    Multiple Choice Questions

    1. What is a primary characteristic of primary immunodeficiencies? A. They are always acquired after birth due to lifestyle choices. B. They are caused by external factors like environmental toxins. C. They are inherited defects in immune system maturation or function. D. They only affect the elderly population.

    2. Secondary immunodeficiencies are best defined as: A. Genetic disorders manifesting at birth. B. Immunodeficiencies secondary to an extrinsic cause. C. The most common form of immunodeficiency worldwide. D. A temporary state of weakened immune response.

    3. Recurrent infections in individuals with primary immunodeficiencies often imply: A. A high efficacy of vaccines in these individuals. B. A specific vulnerability to autoimmune diseases only. C. Inability of the immune system to remember pathogens. D. A common feature across all types of immunodeficiencies.

    4. B cell deficiencies are most likely to increase susceptibility to: A. Encapsulated bacterial infections. B. Only viral infections. C. Fungal infections exclusively. D. Infections by prions.

    5. The treatment for antibody disorders typically does NOT include: A. Hematopoietic stem cell transplantation (HSCT). B. Intravenous immunoglobulins (IVIG). C. Prophylactic antimicrobials. D. Physical exercise programs.

    6. X-linked agammaglobulinemia (XLA) primarily affects which stage of B cell development? A. Transition from pro-B to pre-B cells. B. Maturation of memory B cells. C. Differentiation of plasma cells. D. Initial stem cell differentiation into B cells.

    7. Chronic Variable Immunodeficiency (CVID) is diagnosed primarily in: A. Infancy, just after birth. B. Late childhood to adulthood, commonly in 20-30s. C. Elderly population as a form of immunosenescence. D. Adolescence during puberty.

    8. Which type of immunodeficiency is characterized by a severe deficiency affecting both T and B cells? A. Hyper IgE syndrome. B. X-linked Hyper IgM syndrome. C. Severe Combined Immunodeficiency (SCID). D. Complement deficiencies.

    9. Defects in innate immunity can lead to: A. High susceptibility to autoimmune diseases. B. Uncontrolled inflammation and pyogenic infections. C. Enhanced vaccine efficacy. D. Increased phagocyte motility.

    10. Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED) results from a deficiency in: A. BTK protein. B. WASp. C. AIRE. D. IL-2R gamma chain.

    Answers

    1. C. They are inherited defects in immune system maturation or function.
    2. B. Immunodeficiencies secondary to an extrinsic cause.
    3. D. A common feature across all types of immunodeficiencies.
    4. A. Encapsulated bacterial infections.
    5. D. Physical exercise programs.
    6. A. Transition from pro-B to pre-B cells.
    7. B. Late childhood to adulthood, commonly in 20-30s.
    8. C. Severe Combined Immunodeficiency (SCID).
    9. B. Uncontrolled inflammation and pyogenic infections.
    10. C. AIRE.
  9. User

    Make multiple choice questions testing all of these concepts and also list the answers to them at the end: Antibody disorders Manifest around 5-6 months after maternal antibodies are depleted except CVID which shows up in later childhood and adulthood Recurrent sinopulmonary infections with encapsulated bacteria such as S. pneumoniae and H. influenzae Due to lack of antibodies needed to opsonize and phagocytize encapsulated bacteria Treatment- IVIG and prophylactic antimicrobials Examples: XLA- BTK defect Stops pro-B → pre-B leading to low B cell(CD19+) and low # of all Igs Treatment- IVIG and antimicrobials Hyper IgM- high levels of IgM 2 causes: CD40L deficiency and AID deficiency CD40L- X-linked Impaired B and T cell functions AID- AR Impaired B cells but T cells are normal. B cell cannot isotype switch CVID- Caused by defects in BAFF R (B cell development and survival) and TACI (isotype switching) Commonly diagnosed in 20-30s. Hypogammaglobulinemia with low serum IgG and low IgA or IgM or both. Labs- Impaired response to antigens Normal B cell numbers but low memory B cell Memory B cells cannot undergo class-switching Severe deficiency of plasma cells and impaired somatic hypermutation Some T cell dysfunction in some patients Presentation- Recurrent sinopulmonary infections Giardia and Mycoplasma infections Enteropathy, 20% develop an autoimmunity Treatment- IVIG Selective Ig deficiencies (commonly IgA)- Low IgA only. Increased sinopulmonary and GI infections. Increased atopy and autoimmune diseases. Treatment- antimicrobials

    T cell Early infancy to early childhood onset. Susceptible to intracellular pathogens such as Mycobacteria, Toxoplasma gondii, Leishmania, Pneumocystis jirovecci, and viruses Severe T cell deficiencies can affect B cell function leading to SCID Labs- Lymphopenia Absent DTH (Delayed type hypersensitivity) response Treatment- HSCT

    Mitogens- polyclonal activators of T and B cells. Used to assess ability of lymphocytes to proliferate MHC class I (Bare Lymphocyte Syndrome I)- Lack of MHC I Hyper IgE syndrome (HIES, Job’s Syndrome)- AD STAT3 defect leading to defective TH17 lineage differentiation (neutrophils). Inability to respond to skin and mucosal infections due to poor neutrophil recruitment and lack of antimicrobial peptides Triad of clinical symptoms- recurrent S. aureus cold abscesses, pneumonia, and high serum IgE Severe eczema, non-red and non-tender pustules, asymmetrical face, broad nose, deep-set eyes, big forehead, delayed shedding of primary teeth. “FATED” Coarse Fascial features Cold Staph Abscess Retained 1° Teeth Increased IgE Eczema: Dermatologic problems

    Hyper IgM (CD40L deficiency)- X-linked Impaired B and T cell functions Wiskott-Aldrich Syndrome (WAS)- X-linked. WAS gene mutation for WAS protein (WASp) only in leukocytes and megakaryocytes. WASp is a regulator of B and T cell and platelet development and function through its receptor-mediated signals involved in actin cytoskeleton reorganization. Thrombocytopenia, Eczema, and severe recurrent infections of pyogenic and opportunistic Platelets reduced in size and number Abnormal bleeding (Petechiae and easy bruising) and bloody diarrhea secondary to thrombocytopenia Susceptible to autoimmunity such as hemolytic anemia and vasculitis T cells abnormal numbers and function due to loss of movement, microvilli, immune synapse formation, cytotoxic function Low IgM, no isohemagglutinin and low response to polysaccharides. Normal IgG and increased IgE and IgA Motility and phagocytosis defects in monocytes, macrophages, and dendritic cells Treatment- IVIG, prophylactic antimicrobials, avoid trauma-related bleeding, HSCT, and Gene therapy

    SCID= Both T and B cell are lacking or compromised Mutation in both T and B cells Severe T cell deficiency that can affect the function of B cells Prone to opportunistic infections such as Adenoviruses, Epstein Bar virus, Candida albicans, and P. jirovecii TRECS and HSCT or Thymus replacement for Complete DiGeorge 3 major defects lead to SCID Defects in T cell differentiation- X-linked SCID most common Defects in TCR rearrangement- Omenn syndrome Defects in purine salvage pathway- Adenosine deaminase (ADA) or purine nucleotide (PNP) deficiencies Complete DiGeorge syndrome- 22q11 chromosome defect → no thymus Omenn syndrome- leaky Missense mutation in RAG genes T-B-NK+ X-linked SCID- Mutated IL-2R gene gamma chain. T-B+NK- Adenosine Deaminase Deficiency (ADA)- T-B-NK- Purine Nucleoside Phosphorylase Deficiency (PNP)- T-B-NK-

    Diseases that lead to autoimmunity ALPS- AD Fas defect → uncontrolled T cell proliferation without infection or cancer Splenomegaly and lymphadenopathy Test- large number of CD3+ CD4- CD8- T cells (DN) Autoimmune polyendocrinopathy candidiasis (APECED)- No AIRE → self reactive T cells Immune dysregulation, polyendocrinopathy, enteropathy X-linked disease (IPEX)- X-linked Mutated FOXP3 → lack of Treg tolerance Dermatitis, diarrhea, failure to thrive Systemic autoimmunity triad: Autoimmune enteropathy Autoimmune endocrinopathies Eczematous dermatitis Treatment- HSC

    Complement deficiencies - NOT ON EXAM 3 C3 deficiency- recurrent bacterial infections Properdin or terminal component deficiencies- Neisseria meningitides MBL deficiency- recurrent pneumonia infections in infants Paroxysmal nocturnal hemaglobulinuria (PNH) Hereditary angioedema (HAE) Factor I deficiency

    Phagocytic deficiencies Compromised ability to clear infections due to phagocytosis problems Prone to S. Aureus, fungi and gram-negative bacteria LAD- 2 types I and II I is AR defect in Beta 2 integrin chain of LFA-1 → defect in migration of phagocytes to site of infection II is impaired fucosylation of Leukocyte adhesion molecule sialyl-Lewis-X (CD15) Poor wound healing CGD- Mutated NADPH Oxidase → Impaired killing of phagocytosed bacteria Two testing methods Neutrophils mixed with Phorbol myristate acetate (PMA) and Nitroblue tetrazolium (NBT) which is reduced to dark purple formazan in normal phagocytes Neutrophils mixed with dihydrorhodamine (DHR) with PMA. DHR is oxidized to rhodamine in normal phagocytes CHS- Mutated Lyst (CHS1) gene → Impaired ability to form and traffic vesicles. Azurophilic granules in phagocytic cells. Decrease in neutrophils, intracellular microbial activity Impaired in CD8+ T cell and NK cell cytotoxicity Frequent S aureus, S pyogenes, and S pneumonia infections Lack of pigmentation- albinism Adolescence develop progressive neurological problems Treatment- HSCT

    Defects in innate immunity

    X-linked Hypohidrotic Ectodermal Dysplasia (NEMO deficiency)- IKK-gamma, Recurrent pyogenic infections, abnormal hair, teeth (cone shaped), skin

    Autoinflammatory syndrome- primary immunodeficiency in intracellular receptors in innate immunity leading to uncontrolled inflammation.

    Secondary immunodeficiencies Causes: Irradiation and chemotherapy (immunosuppression) Bone marrow cancers Protein-calorie malnutrition Premature aging Infections

    Immunosenescence- aging of immune system. More prone to infections Less protected by vaccines Longer more severe poorer prognosis of diseases Reactivation of Varicella-zoster and M. tuberculosis Risks forPpneumonia, UTIs, Meningitis, and Gastroenteritis Infections- HIV gp41 — CD4 gp120 — CCR5 or CXCR4 (chemokine receptors)

    Leads to Acquired immunodeficiencies (AIDs) Drugs inhibit - reverse transcriptase, intergrase, and protease activity

  10. Assistant

    Multiple Choice Questions:

    1. When do antibody disorders typically manifest? A. Immediately after birth. B. Around 5-6 months after maternal antibodies are depleted. C. During adolescence. D. In late adulthood.

    2. What is the primary treatment for patients with X-Linked Agammaglobulinemia (XLA)? A. Corticosteroids. B. IVIG and antimicrobials. C. Chemotherapy. D. Surgical intervention.

    3. Which disorder is characterized by high levels of IgM due to a CD40L deficiency? A. Severe Combined Immunodeficiency (SCID). B. Chronic Variable Immunodeficiency (CVID). C. Hyper IgM syndrome. D. Wiskott-Aldrich Syndrome (WAS).

    4. Common infections in patients with Chronic Variable Immunodeficiency (CVID) include: A. Giardia and Mycoplasma infections. B. Skin infections by Staphylococcus aureus. C. Fungal infections of the skin. D. Neisseria meningitidis infections.

    5. Which cellular defect is a hallmark of Severe Combined Immunodeficiency (SCID)? A. Overactive B cells. B. Lack of memory T cells. C. Both T and B cells are lacking or compromised. D. Hyperactive phagocytes.

    6. The symptom "FATED" is associated with which syndrome? A. Hyper IgE syndrome (Job’s Syndrome). B. Autoimmune polyendocrinopathy candidiasis (APECED). C. Chronic Granulomatous Disease (CGD). D. Wiskott-Aldrich Syndrome (WAS).

    7. What is the primary cause of Wiskott-Aldrich Syndrome (WAS)? A. Mutation in the WAS gene affecting WAS protein. B. Deficiency in IgA. C. Excessive production of IgE. D. Impaired MHC class I expression.

    8. A deficiency in which gene is associated with Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED)? A. BTK. B. WASp. C. AIRE. D. FOXP3.

    9. Which treatment is preferred for correcting Severe T cell deficiencies? A. Oral Antimicrobials. B. Hematopoietic Stem Cell Transplantation (HSCT). C. Intravenous Immunoglobulins (IVIG). D. Long-term Corticosteroid Therapy.

    10. Chronic Granulomatous Disease (CGD) is diagnosed via a test that evaluates: A. The ability of neutrophils to form reactive oxygen species. B. Serum Ig levels. C. Wound healing time. D. Lymphocyte proliferation in response to mitogens.

    Answers:

    1. B. Around 5-6 months after maternal antibodies are depleted.
    2. B. IVIG and antimicrobials.
    3. C. Hyper IgM syndrome.
    4. A. Giardia and Mycoplasma infections.
    5. C. Both T and B cells are lacking or compromised.
    6. A. Hyper IgE syndrome (Job’s Syndrome).
    7. A. Mutation in the WAS gene affecting WAS protein.
    8. C. AIRE.
    9. B. Hematopoietic Stem Cell Transplantation (HSCT).
    10. A. The ability of neutrophils to form reactive oxygen species.